BioMaxima S.A. (FRA:944)

Market Cap	11.65M
Revenue (ttm)	13.85M
Net Income (ttm)	152.10K
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	76.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.360
Previous Close	2.330
Day's Range	2.310 - 2.360
52-Week Range	2.120 - 3.180
Beta	n/a
RSI	25.77
Earnings Date	Nov 28, 2025

About BioMaxima

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and r...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 126
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 944

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.

Financial numbers in PLN